-+ 0.00%
-+ 0.00%
-+ 0.00%

FORTRESS BIOTECH INC - ASTRAZENECA'S ANSELAMIMAB TRIAL DID NOT ACHIEVE STATISTICAL SIGNIFICANCE - SEC FILING

Reuters·07/16/2025 21:26:42

Please log in to view news